Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen balks over meeting to review cost of bone cancer drugs
Amgen balks over meeting to review cost of bone cancer drugs
Amgen balks over meeting to review cost of bone cancer drugs
Submitted by
admin
on April 7, 2016 - 9:46am
Source:
Stat
News Tags:
Amgen
drug pricing
Kyprolis
Multiple Myeloma
Headline:
Amgen balks over meeting to review cost of bone cancer drugs
Do Not Allow Advertisers to Use My Personal information
